SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001019056-14-000255
Filing Date
2014-02-14
Accepted
2014-02-14 16:34:08
Documents
1
Group Members
JOSEPH EDELMANPERCEPTIVE ADV

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sarepta_13g.htm SC 13G 69876
  Complete submission text file 0001019056-14-000255.txt   71703
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-54847 | Film No.: 14617460
SIC: 2834 Pharmaceutical Preparations

Mailing Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 499 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 646-205-5340
PERCEPTIVE ADVISORS LLC (Filed by) CIK: 0001224962 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G